Name | cGMP Dependent Kinase Inhibitor Peptide |
---|---|
Synonyms |
L-Glutamic acid, N-(diaminomethylene)-L-ornithyl-L-lysyl-N-(diaminomethylene)-L-ornithyl-L-alanyl-N-(diaminomethylene)-L-ornithyl-L-lysyl-
Alg-Lys-Arg-Ala-Arg-Lys-Glu cGMP-Dependent Protein Kinase Inhibitor Peptide ARG-LYS-ARG-ALA-ARG-LYS-GLU arginyl-lysyl-arginyl-alanyl-arginyl-lysyl-glutamic acid RKRARKE PKG INHIBITOR PROTEIN KINASE G INHIBITOR N-(Diaminomethylene)-L-ornithyl-L-lysyl-N-(diaminomethylene)-L-ornithyl-L-alanyl-N-(diaminomethylene)-L-ornithyl-L-lysyl-L-glutamic acid H-ARG-LYS-ARG-ALA-ARG-LYS-GLU-OH |
Description | PKG inhibitor peptide is an ATP-competitive inhibitor of cGMP-dependent protein kinase (PKG), with a Ki of 86 μM[1]. |
---|---|
Related Catalog | |
Target |
Ki: 86 μM (PKG)[1] |
In Vitro | Summary of experiments showing that intracellular dialysis of postsynaptic cells with PKG inhibitor PKG inhibitor peptide (1 mM) failed to alter the induction of long-term depression (CCh-LTD)[2]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C38H74N18O10 |
Molecular Weight | 943.11 |
Exact Mass | 942.583557 |
PSA | 512.96000 |
LogP | -5.78 |
Index of Refraction | 1.658 |